


Biocomposites appoints two new Directors to strengthen its team for its next phase of growth
Michelle Lewis becomes Human Resources Director
Ciara Airey…

TG Therapeutics and Neuraxpharm Announce Ex-US Commercialization Agreement for BRIUMVI® (ublituximab-xiiy)
Total deal size of approximately ~$650M, including over $150M…

Invizius receives MHRA approval to commence First-in-Human clinical study of H-Guard® Priming Solution
Invizius Limited (“Invizius”), a biotechnology company developing…

IO Biotech Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial at University of California Davis Comprehensive Cancer Center
NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) – IO Biotech (Nasdaq:…

Medicxi Announces $400m Medicxi IV
Fund to focus on its pioneering ‘asset-centric’ investment…

IO Biotech Announces Abstract Accepted for Mini Oral Presentation at IASLC 2023 World Conference on Lung Cancer
NEW YORK, July 25, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq:…

Golgi Neurosciences and Breye Therapeutics announce successful closing of P2X7 receptor antagonist program transfer
Collaboration to advance development of innovative oral small…

Pheon Therapeutics Appoints Industry Veteran Cyrus Mozayeni, MD as Chief Executive Officer
Newly appointed CEO has over 20 years’ experience in company…

IO Biotech Strengthens Executive Management and US Presence with Appointment of Qasim Ahmad, MD, as Chief Medical Officer
Eric Faulkner, currently Sr. Vice President, CMC, appointed…

Futura Medical – Jeff Needham to succeed John Clarke as Non-Executive Chairman of Futura Medical plc
Futura Medical plc (AIM: FUM) ("Futura" or the "Company"), a…

Leucid Bio Appoints Filippo Petti as Chief Executive Officer
London, UK – 18 July 2023 – Leucid Bio (“Leucid” or the…

Synendos Therapeutics AG Co-Founder and SAB Member, Professor Jürg Gertsch, Presents Groundbreaking New Findings on an Endocannabinoid Transporter at Cannabinoid Research Conference
Professor Gertsch identifies novel transport mechanism and…

Futura Medical Announces Agreement With Haleon To Commercialise MED3000 In The USA
Futura Medical plc (AIM: FUM) ("Futura" or the "Company"), a…

Vicore announces the appointment of Ahmed Mousa as CEO
Stockholm, July 13, 2023 – Vicore Pharma Holding AB (publ)…

Neuraxpharm expands outside Europe into Brazil and Mexico
Recently acquired Sanofi portfolio products to be combined with…

Versameb Strengthens its Board of Directors
Significant appointments of experienced drug development…

Sequana Medical announces first patient enrolled in MOJAVE, a US randomized controlled Phase 1/2a study of DSR® 2.0 for treatment of congestive heart failure
US study seeking to confirm strong efficacy data reported…

Destiny Pharma plc – Positive findings from recent SAB meeting
Confirms proposed Phase 3 development pathway and identifies…

Sequana Medical – 1,000th alfapump® implant completed
Extensive real world alfapump experience derisks planned…
We’d love to hear from you.
For more information about Optimum Strategic Communications, please get in touch.
We are specialists with an indepth understanding of how to communicate complex science to investors and corporate stakeholders. We help companies on their journey as they grow and have been trusted by hundreds of clients from around the world, both public and private, large and small.
Locations
- London
- Amsterdam
- Stockholm
- Zurich
- New York